Atrial natriuretic peptide infusion improves ischemic renal failure after suprarenal abdominal aortic cross-clamping in dogs

Critical Care Medicine

Volumn 31, Issue 8, 2003, Pages 2205-2210

  Mitaka, Chieko ^a   Hirata, Yukio ^a   Habuka, Kenichiro ^a   Narumi, Yutaka ^a   Yokoyama, Kuninori ^a   Makita, Koshi ^a   Imai, Takasuke ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Aortic cross clamping; Atrial natriuretic peptide; Dog; Hemodynamics; Ischemia reperfusion injury; Renal function

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CREATININE; RINGER LACTATE SOLUTION; SODIUM CHLORIDE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; AORTA ANEURYSM; AORTA CLAMPING; ARTICLE; ARTIFICIAL VENTILATION; BLOOD GAS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIURESIS; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; KIDNEY BLOOD FLOW; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; URINE VOLUME;

ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM; ATRIAL NATRIURETIC FACTOR; CARDIAC SURGICAL PROCEDURES; CONSTRICTION; DOGS; HEMODYNAMIC PROCESSES; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; PROSPECTIVE STUDIES; RENAL CIRCULATION; REPERFUSION INJURY;

EID: 0041942697     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000080487.20304.2E     Document Type: Article

References (36)

1. Allen BT, Anderson CB, Rubin BG, et al: Preservation of renal function in juxtarenal and suprarenal abdominal aortic aneurysm repair. J Vasc Surg 1993; 17:948-959
2. Breckwoldt WL, Mackey WC, Belkin M, et al: The effect of suprarenal cross-clamping on abdominal aortic aneurysm repair. Arch Surg 1992; 127:520-524
3. Giulini SM, Bonardelli S, Portolani N, et al: Suprarenal aortic cross-clamping in elective abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2000; 20:286-289
4. Sasaki T, Ohsawa S, Ogawa M, et al: Postoperative renal function after an abdominal aortic aneurysm repair requiring a suprarenal aortic cross-clamp. Surgery Today 2000; 30:33-36
5. Paul MF, Mazer CD, Byrick RJ, et al: Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol 1986; 6:427-434
6. Lanese DM, Yuan BH, Falk SA, et al: The effects of atriopeptin III on isolated rat afferent and efferent arterioles. Am J Physiol 1991; 261:F1102-F1109
7. Sonnenberg H, Honrath U, Chong CK, et al: Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol 1986; 250:F963-F966
8. Roy DR: Effect of synthetic ANP on renal and loop of Henle functions in the young rat. Am J Physiol 1986; 251:F220-F225
9. Davis CL, Briggs JP: Effects of atrial natriuretic peptide on renal medullary solute gradients. Am J Physiol 1987; 253:F679-F684
10. Nakamoto M, Shapiro JI, Shanley PF, et al: In vitro and in vivo protective effect of atriopeptin III on ischemic acute renal failure. J Clin Invest 1987; 80:698-705
11. Shaw SG, Weidmann P, Hodler J, et al: Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987; 80:1232-1237
12. Rahman SN, Kim GE, Mathew AS, et al: Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994; 45:1731-1738
13. Mitaka C, Hirata Y, Habuka K, et al: Atrial natriuretic peptide improves gas exchange by reducing extravascular lung water in canine model with oleic acid-induced pulmonary edema. Crit Care Med 2002; 30:1570-1575
14. Burke TJ, Cronin RE, Duchin KL, et al: Ischemia and tubule obstruction during acute renal failure in dogs: Mannitol in protection. Am J Physiol 1980; 238:F305-F314
15. Burke TJ, Arnold PE, Gordon JA, et al: Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. J Clin Invest 1984; 74:1830-1841
16. Gianello P, Carlier M, Jamart J, et al: Effect of 1-28alpha-h atrial natriuretic peptide on acute renal failure in cadaveric renal transplantation. Clin Transplant 1995; 9:481-489
17. Klein HG, Dimitrov D, Atanasova I, et al: Atrial natriuretic factor infusion following acute renal ischemia in anesthetized dogs. Ren Physiol Biochem 1992; 15:73-82
18. Neumayer HH, Blossei N, Seherr-Thohs U, et al: Amelioration of postischaemic acute renal failure in conscious dogs by human atrial natriuretic peptide. Nephrol Dial Transplant 1990; 5:32-38
19. Zimmerman RS, Schirger JA, Edwards BS, et al: Cardio-renal-endocrine dynamics during stepwise infusion of physiologic and pharmacologic concentrations of atrial natriuretic factor in the dog. Circ Res 1987; 60:63-69
20. Huang C-L, Lewicki J, Johson LK, et al: Renal mechanism of action of rat atrial natriuretic factor. J Clin Invest 1985; 75:769-773
21. Katoh T, Sophasan S, Kurokawa K: Permissive role of dopamine in renal action of ANP in volume-expanded rats. Am J Physiol 1989; 257:F300-F309
22. Winaver J, Burnett JC, Tyce GM, et al: ANP inhibits NA(+)-H+ antiport in proximal tubular brush border membrane: Role of dopamine. Kidney Int 1990; 38:1133-1140
23. Holtback U, Brismar H, DiBona GF, et al: Receptor recruitment: A mechanism of interactions between G-protein coupled receptors. Proc Natl Acad Sci U S A 1999; 96:7271-7275
24. Samson WK, Vanatta JC: Atrial natriuretic factor inhibits vasotocin-induced water reabsorption in the toad urinary bladder. Proc Soc Exp Biol Med 1986; 181:169-172
25. Debinski W, Kuchel O, Garcia R, et al: Atrial natriuretic factor inhibits the sympathetic nervous activity, in one-kidney, one-clip hypertension in the rat. Proc Soc Exp Biol Med 1986; 181:173-177
26. Antonucci F, Calo L, Rizzolo M, et al: Nifedipine can preserve renal function in patients undergoing aortic surgery with infrarenal crossclamping. Nephron 1996; 74:668-673
27. Opgenorth TJ, Novosad El: Atrial natriuretic factor and endothelin interactions in control of vascular tone. Eur J Pharmacol 1990; 191:351-357
28. Mitaka C, Hirata Y, Yokoyama K, et al: Improvement of renal dysfunction in dogs with endotoxemia by a nonselective endothelin receptor antagonist. Crit Care Med 1999; 27:146-153
29. Mason J, Torhorst J, Welsch J: Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 1984; 26:283-293
30. Burke TJ, Arnold PE, Schrier RW: Prevention of ischemic acute renal failure with impermeant solutes. Am J Physiol 1983; 244:F646-F649
31. Bilzer M, Witthaut R, Paumgartner G, et al: Prevention of ischemia/reperfusion injury in the rat liver by atrial natriuretic peptide. Gastroenterology 1994; 106:143-151
32. Kiemer AK, Vollman AM, Bilzer M, et al: Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J Hepatol 2000; 33:236-246
33. Welborn MB, Oldenburg HAS, Hess PJ, et al: The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair. Crit Care Med 2000; 28:3191-3197
34. Valsson F, Ricksten SE, Hedner T, et al: Effects of atrial natriuretic peptide on acute renal impairment in patients with heart failure after cardiac surgery. Intensive Care Med 1996; 22:230-236
35. Sward K, Valson F, Ricksten SE: Long-term infusion of atrial natriuretic peptide (ANP) improves renal blood flow and glomerular filtration rate in clinical acute renal failure. Acta Anaesthesiol Scand 2001; 45:536-542
36. Allgren RL, Marbury TC, Rahman SN, et al: Anaritide in acute tubular necrosis. N Engl J Med 1997; 336:828-834